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                                                                                        INTRODUCTION
CHAPTER-1
1-INTRODUCTION
1.1 INDIAN SYSTEM OF MEDICINE 1, 2
                  The WHO estimates about 80 percentage of population living in the
developing  countries  rely  exclusively  on  traditional  medicine  for  their  primary
health care needs. India has an ancient heritage of traditional medicine. The Indian
traditional  medicine  is  based  on  the  different  system  including  Ayurveda,
Homeopathy, Siddha, Unani. With emerging interest in the world to adopt and study
the traditional system and exploit their potentials based on the different health care
system, the evaluation of the rich heritage of the traditional medicine is essential.
                  Almost in all traditional medicine, the medicinal plant plays a crucial role
in the traditional medicine. India has the rich heritage of traditional medicine and the
traditional health care system have been flourishing for many centuries. In India, the
Ayurvedic system of medicine developed an extensive use of medicine from plants
dating from at least 1000 B.C. Western medicine continuous to show the influence of
ancient practices. For ex, cardiac glycoside from Digitalis pupurea, Morphine from
Papavera  samnifera,  Reserpine  from  Rauwolfia  species,  Quinine  from  cinchona
species and Arteminsin, as active anti malarial compound from Artemisia annua, etc.
Show the influence of traditional medicine in the traditional medicine.
                Medicinal plants and its herbal formulation are the common elements in
Ayurveda, Homeopathy, Siddha and Unani system of medicines in India and China.
The  use  of  modern  isolation  techniques  and  pharmacological  testing  procedure
means  that  new  plant  drugs  usually  find  their  way  into  medicine  as  purified
substances rather than galenical preparations. The plant kingdom still holds many
species  of  plants  containing  substances  of  medicinal  value  which  yet  to  be
discovered; large number of plants are constantly being screened for their possible
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pharmacological  value  (  particularly  for  their  anti  inflammatory,  hypotensive,
hypoglycaemic,  amoebicidal,  anti  fertility,  cytotoxicity,  antibiotics,  and  anti
parkinsonism properties). 
              Pharmacognosy has been basically evolved as an applied science pertaining
to the study of all types of the drugs of natural origin. However, its subject matter is
directed towards the modern allopathic medicine. During the course of development,
many civilizations has raised and perished but the systems of medicines developed
by them in various parts of the world are still practised, and are also popular as the
alternative system of medicines.   These are alternative systems in the sense that
modern allopathic system has been globally acclaimed as the principal system of the
medicine, and so all the other systems prevent and practised in various parts of the
world  are  supposed  to  be  alternative  systems.  The  philosophy  and  the  basic
principles of these so called alternative systems might differ significantly from each
other, but the fact cannot be denied that these systems have served the humanity for
the treatment and management of disease and also for maintenance of good health.
About 80 % of the world population still rely and use the medicines of traditional
systems.
               Traditional Chinese medicine in China, Unani system in Greece, Ayurvedic
system in India, Amachi in Tibet or more recently Homeopathy in Germany  are
these systems of medicine which were once practised only in the respective areas or
subcontinents of the world, are now popularly practised all over the world.   The
World Health Organization (WHO) is  already taking much interest in indigenous
systems of  medicine and coming forward to exploit  the scientific validity of  the
medicines used since traditions.
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1.2 AYURVEDIC MEDICINES1, 2
Ayurvedic  medicine  (also called  Ayurveda)  is  one  of  the  world’s  oldest  medical
systems. It originated in India and has evolved there over thousands of years. In the
United  States,  Ayurvedic  medicine  is  considered  complementary  and  alternative
medicine.  A group  of  diverse  medical  and  health  care  systems,  practices,  and
products  that  are  not  presently  considered  to  be  part  of  conventional  medicine.
Complementary  medicine  is  used  together  with  conventional  medicine,  and
alternative  medicine  is  used  in  place  of  conventional  medicine. Complementary
medicine more specifically, a CAM  whole medical system. A complete system of
theory and practice that has evolved over time in different cultures and apart from
conventional  medicine.  Examples  of  whole  medical  systems  include  traditional
Chinese  medicine,  Ayurvedic  medicine,  Homeopathy  and  Naturopathy. Many
therapies  used  in  Ayurvedic  medicine  are  also  used  on  their  own  as  CAM  for
example,  herbal  massage,  pressing,  rubbing,  and  moving muscles  and  other  soft
tissues of the body, primarily by using the hands and fingers. The therapy increased
the  flow of  blood and  oxygen  to  the  massaged  area.  This  fact  sheet  provides  a
general  overview  of  Ayurvedic  medicine  and  suggests  sources  for
additional information. 
1.2.1 Ayurvedic Medicine in India
Ayurvedic medicine, as practiced in India, is one of the oldest systems of medicine
in the world.  Many Ayurvedic practices  earlier  written records and were  handed
down by word of mouth. Two ancient books, written in Sanskrit more than 2,000
years ago, are considered the main texts on Ayurvedic medicine—Caraka Samhita
and Sushruta Samhita. The texts describe eight branches of Ayurvedic medicine:
• Internal medicine
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• Surgery
• Treatment of head and neck disease
• Gynaecology, obstetrics, and paediatrics
• Toxicology
• Psychiatry
• Care of the elderly and rejuvenation
• Sexual vitality.
Ayurvedic medicine continues to be practiced in India, where nearly 80 percent of
the  population  uses  it  exclusively  or  combined  with  conventional  (Western)
medicine. It is also practiced in Bangladesh, Sri Lanka, Nepal, and Pakistan.
Most  major  cities  in  India  have  an  Ayurvedic  college  and  hospital.  The  Indian
government  began  systematic  research  on  Ayurvedic  practices  in  1969,  and  that
work continues.
Underlying Concepts
Ayurvedic medicine has several key foundations that pertain to health and disease.
These concepts have to do with universal interconnectedness, the body’s constitution
(prakriti), and life forces (doshas).
Interconnectedness Ideas about the relationships among people, their health, and
the universe form the basis for how Ayurvedic practitioners think about problems
that affect health. Ayurvedic medicine holds that:
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• All things in the universe (both living and nonliving) are joined together.
• Every human being contains elements that can be found in the universe.
• Health will be good if one’s mind and body are in harmony, and one’s interaction
with the universe is natural and wholesome.
• Disease arises when a person is out of harmony with the universe. Disruptions can
be physical, emotional, spiritual, or a combination of these.
Constitution  (prakriti). Ayurvedic  medicine  also  has  specific  beliefs  about  the
body’s constitution. Constitution refers to a person’s general health, the likelihood of
becoming out of balance, and the ability to resist and recover from disease or other
health problems.
The constitution is called the prakriti. The prakriti is a person’s unique combination
of  physical  and psychological  characteristics  and  the  way the body functions  to
maintain health. It is influenced by such factors as digestion and how the body deals
with  waste  products.  The  prakriti is  believed  to  be  unchanged  over  a
person’s lifetime.
Life forces (doshas). Important characteristics of the prakriti are the three life forces
or  energies  called  doshas,  which  control  the  activities  of  the  body.  A person’s
chances of developing certain types of diseases are thought to be related to the way
doshas are balanced, the state of the physical body, and mental or lifestyle factors.
Ayurvedic medicine holds the following beliefs about the three doshas:
• Each  dosha is made up of two of five basic elements: ether (the upper regions of
space), air, fire, water, and earth.
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• Each  dosha has a particular relationship to bodily functions and can be upset for
different reasons.
• Each person has a unique combination of the three  doshas, although one  dosha is
usually  prominent.  Doshas are  constantly  being  formed  and  reformed  by  food,
activity, and bodily processes.
• Each dosha has its own physical and psychological characteristics.
• An imbalance of  a  dosha will  produce  symptoms that  are unique to  that  dosha.
Imbalances may be caused by a person’s age, unhealthy lifestyle, or diet; too much
or too little mental and physical exertion; the seasons; or inadequate protection from
the weather, chemicals, or germs.
The doshas are known by their original Sanskrit names: vata, pitta, and kapha.
The  vata dosha combines  the  elements  Ether  and Air.  It  is  considered  the  most
powerful dosha because it controls very basic body processes such as cell division,
the heart, breathing, discharge of waste, and the mind. Vata can be aggravated by for
example fear, grief, staying up late at night, eating dry fruit, or eating before the
previous meal is digested. People with  vata as their main  dosha are thought to be
especially susceptible to skin and neurological conditions, rheumatoid arthritis, heart
disease, anxiety and insomnia.
The pitta dosha represents the elements fire and water. Pitta controls hormones and
the  digestive  system.  A person  with  a  pitta imbalance  may experience  negative
emotions such as anger and may have physical symptoms such as heartburn within 2
or 3 hours of eating. Pitta is upset by for example eating spicy or sour food, fatigue,
or spending too much time in the sun. People with a predominantly pitta constitution
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are thought to be susceptible to hypertension, heart disease, infectious diseases, and
digestive conditions such as Crohn’s disease.
The kapha dosha combines the elements water and earth. Kapha helps to maintain
strength and immunity and to control growth. An imbalance of the kapha dosha may
cause nausea immediately after eating. Kapha is aggravated by for example, greed,
sleeping during the daytime, eating too many sweet foods, eating after one is full,
and  eating  and  drinking  foods  and  beverages  with  too  much  salt  and  water
(especially in the springtime). Those with a predominant kapha dosha are thought to
be vulnerable to diabetes, cancer, obesity, and respiratory illnesses such as asthma.
 1.3 UNANI SYSTEM OF MEDICINE1, 2
Unani  system  of  medicine  is  originated  in  Greece  by  the  Greek  philosopher,
physician  Hippocrates  (460-377  B.C),  who  freed  medicine  from  the  realm  of
superstition and magic, and gave it the status of science. The theoretical frame work
of Unani medicine is based on the teachings of Hippocrates. After him, a number of
other Greek scholars followed the system consider. Among them Galen (131-212
A.D) was one to stabilize its foundation, on which Arab physicians like Razzes (850-
925  A.D)  and  Avicenna  (980-1037 A.D)  constructed  as  imposing  edifice.  Unani
medicine got its importance among the other systems of medicine in Egypt, Syria,
Iraq, Persia, India, China and other Middle East and Far East countries. In India,
Arabs introduced Unani system of medicine, and soon it enriched in India.
                Unani medicine is based on the Greek philosophy. According to basic
principles of Unani,  the body is  made up of four basic elements,  i.e.  Earth,  Air,
Water and Fire, which have different Temperaments, i.e. Cold, Hot, Wet and Dry.
After  mixing  and  interaction  of  four  elements,  a  new  compound  having  new
temperament comes into existence, i.e. Hot Wet, Hot Dry, Cold Wet and Cold Dry.
The body has the simple and compound organs, which got their nourishment through
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four  humours,  i.e.  blood,  phlegm,  yellow bile  and  black  bile.  The  humour  also
assigned temperament as blood i.e. hot and wet; Phlegm is cold and dry. Health is a
state of body in which there is equilibrium in the humours and functions of the body
are normal in accordance to its own temperament and the environment.
        When the equilibrium of the humours is disturbed and functions of the body are
abnormal,  in  accordance  to  its  own  temperament  and  environment,  that  state  is
called  disease.  Unani  medicine  believes  in  promotion  of  health,  prevention  of
disease  and  cure.  Health  of  human  is  based  on  the  six  essentials  (Asbabe  sitta
Zaroorya),  if  these  are  followed  health  is  maintained;  otherwise,  there  will  be
disease. Six essentials are atmospheric air, drinks and food, sleep and wakefulness,
excretion and retention, physical activity and rest and mental activity and rest. 
1.4 HOMEOPATHIC SYSTEM OF MEDICINE 2
  Homeopathy is  a  specialised  system of  therapeutics,  developed  by Dr  Samuel
Christian Friedrich Hahnemann (1755- 1843),  a general physician, chemist and a
pharmacist, based on natural law of healing: similia similibus curantur, which means
‘Likes are cured by likes’. Homois means like (similar) and pathos means treatment.
Thus, Homeopathy is a system of treating diseases or suffering by the administration
of the drugs that possess power of producing similar suffering (disease) in healthy
human beings. Dr Hahnemann believed that symptoms are no more than an outward
reflection of the body’s inner fight to overcome illness: it is not a manifestation of
the illness itself. This law of similar for curing diseases has being in use since the
time of Hippocrates, father of medicine.  Dr Hahnemann who developed it in to a
complete system of therapeutics enunciating the law and its application in 1810.
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1.4.1 FUNDAMENTAL PRINCIPLES OF HOMEOPATHY 1, 2
             Homeopathy as a science of medical treatment has a philosophy of its own,
and its therapeutics is based on certain fundamental principles that are quite distinct
and  different  between  from  those  of  other  school  of  medical  science.  These
fundamental principles were discussed by Hahnemann in different sections of his
medicine and philosophy.
They are as follows:
1. Law of similia. 
2. Law of simplex. 
3. Law of minimum.
4. Drug proving.
5. Drug dynamization or potentiation.
6. Vital force.
7. Acute and chronic disease.
8. Individualization.
9. Direction of cure.
1.5 AROMATHERAPHY 1, 2
                  The word Aromatheraphy means treatment using scents. It refers to the
use of essential oils in Holistic healing it improve health and emotional well being,
and in restoring balance to the body. Essential oils are aromatic essences extracted
from plants, flowers, trees, fruit, bark, grasses and seeds. There are more than 150
types  of  oils  that  can  be  extracted.  These  oils  have  distinctive  therapeutic,
psychological and physiological properties that improve health and prevent illness.
All essential oils have unique healing a valuable anti septic properties. Some oils are
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anti  viral,  anti  inflammatory,  anti  pain  relieving,  antidepressant,  stimulating,  and
relaxing, expectorating, support digestion and have diuretic properties too.
            Essential oils get absorbed into our body and exert an influence on it. The
residue gets dispersed from the body naturally. They can also affect our mind and
emotions.  They  enter  the  body  in  three  ways:  by  inhalation,  absorption  and
consumption. Chemically,  essential oils are a mixture of organic compounds like
ketones,  terpenes,  esters,  alcohol,  aldehyde  and  100  of  other  organic  molecules
which  are  extremely  difficult  to  classify,  as  they  are  small  and  complex.  The
essential  oils molecules are small they penetrate human skin easily and enter the
bloodstream directly and finally get flushed out through our elementary system.
Some of the common essential oil used in Aromatherapy
1. Clary sage (saliva scared)
2. Eucalyptus (eucalyptus globules)
3. Geranium (pelargonium graveolens)
4. Lavender (citrus lemon)
5. Peppermint (mentha pipertia)
1.6 SIDDHA SYSTEM OF MEDICINE 2
Siddha medicine is practised in southern India. The origin of the Tamil language is
attributed to the sage Agasthya, and the origin of Siddha medicine is also attributed
to him. Before the Aryan occupation of Sind region and the Gangetic plain, there
existed in the southern Indian, on the banks of the river Cauvery and Tamiraparani, a
civilization which was highly organized. 
1. This civilization has the system of medicine to deal with problem of sanitation and
treatment of  disease.  This is  the Siddha system of  medicine.  The therapeutics of
Siddha medicine consists mainly of the use of metals and minerals where as in the
earlier Ayurveda.
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2. There is mention of mercury, sulphur, copper, arsenic and gold used a therapeutic
agents. 
1.6.1 PRINCIPLE OF SIDDHA SYSTEM OF MEDICINE 2 
The universe consists of to essential entities: matter and energy the Siddha called
them Siva (male) and Sakthi (female, creation). Matter cannot exist without energy
inherent in it  and vice versa. The two co exist and are inseparable. They are the
primordial  elements (Buddha’s)  and are not  be confused with modern chemistry.
Their names are Mann (solid), Neer (fluid), Thee (radions), Vaayu (gas) and Agasum
(ether).  These  five  elements  (Buddha’s)  are  present  in  every  substance,  but  in
different  proportions.  Earth,  water,  fire,  air  and  ether  are  manifestation  of  five
elements.
      The human beings made up these five elements indifferent combination, the
physiological function in the body is mediated by three substances (dravyas), which
are made up of the five elements. They are vatham, pitham and karpam. In each and
every cell of the body these three doshas coexist and function harmoniously. 
The seven dhatus are as follows:
1. Rasa (lymph).
2.  Kurudhi (blood).
3. Tasai (muscle).
4. Kozhupu (adipose tissue).
5. Ezhumpu (bone).
6. Majjai (marrow).
7. Sukkilam and Artavam (male and female hormones)
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CHAPTER 2
2. ASTHMA REVIEW3, 4, 5
Asthma is a hyper reactive airway disease running a chronic course; it has
worldwide prevalence and is a common cause hospitalization in children. It  is
estimated that currently 300 million peoples suffer from asthma with a possibility
of an additional 100 million likely to suffer from the disease over the next 15-20
years.
Asthma is a chronic inflammatory disorder of the airway in which many
cells and cellular elements play a role, in particular, mast cells, eosinophils, T-
lymphocytes,  macrophages,  neutrophils  and  epithelial  cells.  In  susceptible
individuals,  this  inflammation  causes  recurrent  episodes  of  wheezing,
breathlessness,  chest  tightness  and  coughing,  particularly  at  night  or  in  the
morning.  These  episodes  are  usually associated with  widespread  but  variable
airflow obstruction that is reversible either spontaneously or with treatment. The
inflammation  also  causes  an  associated  increase  in  the  existing  bronchial
responsiveness to a variety of stimuli.
2.1 ETIOLOGY
There are two types of asthma; 1. Allergic or extrinsic 2. Idiosyncratic or
intrinsic. Allergic asthma is a result of an antigen/antibody reaction on mast cells
in the respiratory tract.  This type is  often associated with a  family history of
atopy (allergic diseases) such as eczema. Idiosyncratic asthma or intrinsic asthma
is  a  result  of  neurological  imbalances  in  the  autonomic  system in which  the
system in which the sympathetic and parasympathetic systems are not properly
coordinated.
The causes  for  asthma are  many including environmental  and genetic
factors. Atopy is the strongest genetic predisposition for the development of an
IgE response to common aeroallergens. Most cases of childhood asthma (90%)
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are allergic in nature; it is referred to as extrinsic asthma. In this form of the
disease, the inflammatory reaction is a result of abnormal response to common
aeroallergens and environmental allergens. The late includes dust mites, animal,
pollen,  moulds,  fungi,  cockroaches,  fossil  fuels,  strong  fumes,  inhalation  of
irritants (sprays and paints),  cigarette smoke and exposure to cold and humid
weather.  The environmental factors act as triggers in those persons who have
inflammatory changes in their respiratory passages and are highly susceptible to
acute attacks  of  asthma.  The other  important  causes  of  asthma includes  viral
respiratory infections,  exercise  (hyperventilation),  chronic sinusitis  or  rhinitis,
gastroesophageal  reflux  disease  (GERD)  and  drug-induced  asthma
(aspirin,NSAIDs,β blockers, cholinergic drugs). In exercise induced asthma, the
contributing factors include exposure to cold or dry weather and environmental
pollutants (sulphur, ozone).
2.2 PATHOPHYSIOLOGY
Chronic  inflammatory  reaction  is  the  characteristic  features  in  the
pathogenesis  of  bronchial  asthma  which  results  in  intermittent  airflow
obstruction  and  bronchial  hyper  responsiveness.  The  airway  obstruction  in
asthma  is  due  to  factors  that  includes  bronchospasm oedema  of  the  airway,
increased mucus secretion, cellular infiltration of the airway walls and injury to
the  airway epithelium.  Repetition  of  the  inflammatory  events  in  asthma  can
cause irreversible functional  changes in the airway passages,  a process called
remodelling.  The  remodelled  airway  passages  are  persistently  narrow  as  the
disease progresses and become less and less responsive to drug treatment. The
mechanism of inflammation in asthma may be acute, sub acute or chronic. 
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2.3 INFLAMMATORY REACTION
An attack of asthma begins when the allergens is inhaled. The allergen binds
to IgE antibodies that have binding side for the allergens mast cells in the lungs.
Binding of allergen to IgE triggers exocytosis of the mast cells with the release of
histamine  leukotrienes.  Leukotrienes  cause  the  smooth  muscle  cells  of  the
bronchi to contract, narrowing the lumen of the bronchi. This is the early phase.
Next,  they  attract  on  accumulation  of  the  inflammatory  cells,  especially
eosinophils-leading to production of mucus. This is the late phase which occurs
4-6hrs after the early phase.
 Activation of helper T cells, in particular, a sub group called Th2  cells (CD4+T
cells producing Th2)
 Th2 cells over produce interleukins (ILs)
 Interleukins 4, 5, 9 and 13may be responsible for a first phase asthma attack.
These  interleukins  stimulate  the  release  IgE.  People  with  both  asthma  and
allergies appear to be predisposed to over production of IgE.
 During an allergic attack, these IgE antibodies can bind to mast cells present in
the lungs, and also in this skin and mucus membranes. This binding triggers the
release  of  histamine  and  leukotrienes  which  are  responsible  for  the  airway
spasms.
 Another cytokine, IL5, appears to contribute to late phase inflammatory reaction.
This ILs releases Eosinophils. These cells accumulate and remind in the airways
after the first attack. Activation of Eosinophils initiates contraction of bronchial
smooth  muscles,  increased  micro  vascular  permeability,  induction  of  airways
hyper responsiveness and mucus production. The pathological changes in asthma
and the mediators responsible are summarised.
TABLE:1 
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Pathological
changes
Mediator responsible
Contraction  of
bronchial  smooth
muscle  causing
bronchospasm
Histamine(H1  receptor  –  mediated
action),  leukotrienes  C4,D4,E4,
prostaglandins & TXA2,  bradykinin,
platelet activating factor (PAF)
Mucosal oedema
H1  receptor  mediated  action,
leukotrienes  C4,D4,E4,  prostaglandins
&  bradykinin,  platelet  activating
factor (PAF)
Airway  hyper
reactivity
Anaphylaxis, Eosinophil chemotactic
factors,  neutrophil  chemotactic
factors, LTB4, PAF.
Mucus secretion
Histamine  (H1  receptor  –  mediated
action),  leukotrienes  C4, D4,  E4,
prostaglandins & TXA2,  bradykinin,
platelet  activating  factor  (PAF),
Eosinophils.
Inflammatory cells released in asthma include mast cells, degranulation
of which causes release of histamine; eosinophils which initiate contraction of
bronchial  smooth  muscles,  increase   microvascular  permeability  and  induce
airway responsiveness, neutrophils having a passive effector role in inflammation
via phagocytosis and release of performed enzymes and cyto toxic compounds;
and macrophages which play a major role in the pathogegesis of injury and tissue
repair  and  are  involved  in  airway  remodelling  through  secretion  of  growth
factors  such  as  platelet  derived  growth  factor  (PDGF),  and  basic  fibroblast
growth factor (bFGF) of TGF – B. 
2.4 INFLAMMATORY MEDIATORS:
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2.5 SYMPTOMS:
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 Chest pain,
 Wheezing, 
 Cough, 
 Difficult to breath, etc.,
2.6 INFLAMMATORY REACTION IN BRONCHIAL ASTHMA
Early phase → activation of Th2 cells → interleukins 4,9,13 production ↑ 
↓
                                                             Levels of Ig E ↑
↓
  Late phase                          Allergen →binding of IgE to the mast cells
↓ ↓
            Release of IL5             Release of histamine and leukotrienes
           ↓ ↓
             Eosinophils ↑            Bronchoconstriction, bronchospam 
 ↓ ↓
       Activation of Eosinophils              hyper reactivity ↑
      Activation of neutrophils ↓
      Activation of macrophages                Attack bronchial asthma
2.7 TREATMENT FOR ASTHMA:
1. SYMPATHOMIMETIC AGENTS:
Page 18
ASTHMA REVIEW
 Salbutamol
 Terbutaline 
 Metaproterenol
 Fenoterol
 Bitolterol
 Pirbuterol 
 Salmeterol 
 Formoterol
2. METHL XANTHINE DERIVATIVES:
 Theophylline 
 Aminophylline
 Choline theophyllinate
 Hydroxyethyl theophylline 
 Theophylline ethanolate of piperazine
 Doxophylline
3. ANTI CHOLINERGIC:
 Ipratropium bromide
 Tiotropium bromide
4. LEUKOTRIENE ANTAGONISTS:
 Montelukast
 Zafirlukast
 Ziluten
5. MAST CELL STABILIZERS:
 Sodium cromoglycate
 Ketotifen
6. CORTICOSTEROIDS:
 SYSTEMIC: 
 Hydrocortisone
 Prednisolone
 Methyl prednisolone
 Dexamethasone
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 INHALATION: 
 Beclomethasone dipropionate 
 Budesonide
 Fluticasone dipropionate
 Mometasone fumarate
 Cicleoside
 Triamcinolone
 Flunisolide
7. ANTI IgE ANTIBODY:
 Omalizumab
2.8 CLINICAL MANAGEMENT OF ASTHMA:
 Bronchial  asthma  is  a  chronic  debilitating  disease  associated  with
morbidity  and  mortality.  Judicious  management  of  the  disease  is  essential
depending  upon  the  severity  of  the  disease.  Treatment  of  childhood  asthma
requires  special  attention  as  children  are  very  vulnerable  and  present  with
varying degrees of clinical features often requiring regular visits to hospital. A
general  guideline  stipulates  that  the  smallest  dose  of  the  drug  needed  to
adequately control the symptoms should be used. Patients with more frequent or
severe symptoms or with impaired lung function should be treated with regular
prophylactic therapy such as inhaled glucocorticoids, if necessary in the higher
doses depending on the severity of the symptoms. Long acting β2 agonists such
as salmoterol and formoterol may be added to assist rapid control of symptoms.
Leukotriene modifying agents such as montelukast are quiet helpful in children
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for prophylactic use to prevent exacerbations of asthma likely to occur when they
are exposed to known and unknown allergens including environmental allergens.
One important consideration for the therapy of asthma is the possibility of the
drug tolerance and drug toxicities which may limit their usefulness and require a
change in the drug.
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3-LITERATURE REVIEW
Mukesh Kr. Singh et al.6
The   chemical   constituents   such   as   carbohydrates,  flavonoids,
phenolics, steroids, and terpenes were found so while administered to the rats at
100mg/kg and 200mg/kg of Aqueous  extracts  of  leaves  of  Clerodendrum
serratum  possess bronchodilator property.
Jatin Sharma et al.7
Ayurvedic science has propagated the use of Clerodendrum serratum as
effective  treatment  against  asthma,  bodyache,  cholera,  eye  disorder,  ulcers,
snake-bite, wound, tuberculosis and epilepsy. Stimasterol, α-spinasterol, luteolin,
luteolin-7-0 glucuronide, apigenin, baicalin and scutellarin 7-0 glucuronide are
found in leaf based upon the above molecules steroids and flavonoids used for
anti asthmatic activity.
Neeta Shrivastava Tejas Patel et al.8
C.serratum Leaves are reported to be used as medicine for the treatment
of asthma, pyreticosis, cataract, malaria, and diseases of blood, skin and lung. To
prove these ethno-medical claims, some of these species are being extensively
studied for their biological activities using various animal models. Along with
biological  studies,  isolation and identification studies of chemical  constituents
and  its  correlation  with  the  biological  activities  of  the  genus  has  also  been
studied. The major chemical components reported from the genus are phenolics,
steroids, di- and triterpenes, flavonoids and volatile oils.
Farah Farokhi et al.9
Plantago  major(P.  major)  is  one  of  the  medicinal  crops  in  the  world
which  has therapeutic properties for treatment of respiratory and gastrointestinal
diseases.  Theophylline  is  commonly  used  for  the  treatment  of  respiratory
diseases. In this study, we investigated the protective effects of hydro-alcoholic
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extract of P. major on lung in asthmatic male rats. in asthmatic  group. The  mean
number  of  mast  cells  was significantly  increased  (p<0.05).  Thickness of
alveolar epithelium and accumulation  of glycoprotein in airways was increased.
Moreover, in some of alveolar sac haemorrhage was observed. Administration of
p.major extract in asthmatic rats restored these changes towards normal group.
Ziad Shraidehet al.10
This study is an attempt to reveal the effects of narghile smoking on the
cellular level, through exposing a group of  experimental  albino  rats  to  the
smoke   of   two   types   of   narghile   tobacco-derived   products:   flavored
(moassal)  and unflavored (tumbak), for three months on a daily basis, using  a
specially   designed   smoking   machine.  The  most  prominent  histological
changes  were  an  abnormal  proliferation  in  the  epithelium  of  trachea,
disruption  of  its  cilia,  and  a  marked hyperplasia in the connective tissue of
lung alveoli.
Surendra Adusumalli et al.11
Treatment with aqueous extract of  Pistacia Integerrima galls showed a
dose dependent effect on disruption rate of actively sensitized mesenteric mast
cells of albino rats when challenged with antigen (horse serum along with triple
antigen  vaccine).Aqueous  extract  of  galls  treatment  for  ten  days  resulted  in
significant  protection  against  histamine  aerosol-induced  bronchospasm  in
guinea  pigs  and  showed  the  spasmolytic  activity  against  histamine induced
contractions in isolated guinea pig tracheal chain preparation.
Bhoomika R. Goyal et al.12
We  have  studied  the  bronchoprotective  effect  of  ethanolic  extract  of
Achyranthes  aspera Linn.  in  toluene  disocyanate  (TDI)  induced  occupational
asthma in wistar rats. TDI sensitized rats exhibited asthmatic symptoms while A.
As per and dexamethasone treated rats did not show any airway abnormality. The
neutrophils and eosinophils in blood were decreased significantly; the total cells
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and each  different  cell  in  particular  eosinophils  in  BAL fluid were  markedly
decreased  in  treatment  groups  as  compared  to  TDI  sensitized  rats.  The
antioxidant  activity and histopathological  observations  also showed protective
effect.
S.M. Vidya et al.13
The root bark extracts of  Clerodendrum serratum  contains D-mannitol,
stigmasterols,  three  triterpenoids  such  as  oleanolic  acid,  queretaric  acid  and
cerratagenic  acid  (Banarjee  et  al.  1969).  The  plant  was  investigated  for  its
potential activity viz.,anti-inflammatory, analgesic, antipyretic activity.
Abeer A.A. Salama et al.14
To evaluate the efficacy of fish oil (FO) alone or combined with half the
dose  of  dexamethasone  (DEX)  in  experimentally-induced  bronchial  asthma
Asthma was induced in the remaining groups by ovalbumin (OVA) sensitization
(1 mg/kg OVA; i.p.) for 3 consecutive days followed by 1% OVA challenge (1
day/week for 3 weeks). One group was left untreated (positive control). In the
remaining groups,  test  agents  were  orally administered 1 h  before each OVA
challenge as follows: group 3 received dexamethasone (DEX; 1 mg/kg), groups
4-6: received FO (1, 2 and 3 g/kg) and group 7 received FO (1.5 g/kg) plus DEX
(0.5mg/kg).  Lung  function  tests  were  assessed  12  min  after  the  last  OVA
challenge  and  24  h  thereafter,blood  films  were  prepared  for  assessment  of
eosinophil count and blood samples were collected for assessment of serum total
protein  as  well  as  immunoglobulin  E  (Ig-E)  levels.  Lungs  were  isolated  for
histopathological  assessment and determination of tumor necrosis factor-alpha
(TNF-α) content. Additionally the effects of test agents were evaluated in acetyl
choline (ACh; 0.003-0.03%)-induced airway constriction. Results FO alone and
combined with DEX attenuated  OVA-induced  changes in  lung function tests,
reduced OVA-induced increase in eosinophil count, serum total protein and Ig-E 
Levels  as  well  as  lung  TNF-α  content  and  reduced  airway  remodelling.
Moreover,  FO  and  DEX  inhibited  ACh-induced  airway  constriction.
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Conclusions: FO can be used alone or combined with a lower dose of DEX in
treatment of bronchial asthma.
Neelmani Chauhan et al.15
Treatment  with  alcoholic  extract  of  clitorea  ternatea  (400  mg/kg,
p.o)  showed   significant   protection   against   histamine   aerosol   induced
bronchospasm  in   Wister   rats.   The   results   of   the   histamine-   induced
bronchospasm  paradigms   demonstrate   bronchospasmolytic   activity   of
ethanolic  extract  of clitorea ternatea (400 mg/kg, p.o.). Clitorea ternarea shows
47.45 % protection against histamine induced bronchoconstriction in rats.
DJ Taur et al.16
In present study ethanol extract of  Abrus precatorius leaves (EAPL) at
doses of 100, 125, 150mg/kg i.p were evaluated for preliminary phytochemical
screening,  acute  toxicity  studies  and  egg  albumin  induced  mast  cell
degranulation in mice and passive cutaneous anaphylaxis in rats.the results  of
present investigation showed that the LD50 of EAPL is more than 300 mg/kg.
EAPL  (100-150mg/kg,  i.p.)  significantly  protect  egg  albumin  induced
degranulation of mast cell and inhibit area of leakage of dye in passive cutaneous
anaphylaxis.  Phytochemical  studies  observed  presence  of  saponin,  alkaloids,
flavonoids,  and  glycosides.  In  conclusion  EAPL  possesses  anti  asthmatic
potential.
Priyashree Sunita et al.17
The  effect  of  Fr-Et  and  Fr-Me  were  studied  on  acetylcholine  and
histamine  aerosol-induced  broncospasm  using  guinea  pigs  as  experimental
animals. Also, the effects of these fractions were evaluated on the isolated guinea
pig  tracheal  preparations.  Besides  this  mast  cell  degranulation  effect  was
assessed using egg albumin and compound 48/80on rat  peritoneal  mast  cells.
Significant increase in preconvulsion time was observed due to  pre-treatment
with the fractions when guinea pigs were exposed to histamine and acetylcholine
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aerosol.  Fr-Et  and  Fr-Me significantly  increased  the  preconvulsion  in  a  dose
depended manner that suggestive of bronchodilating activity.
Dnyaneshwar J Taur et al.18
Ethanol extracts of  C. grandis fruit (ECGF) at 100,125 and 150 mg·kg,
i.p., was evaluated for mast cell stabilizing, anti anaphylactic and antihistaminic
activity  using  egg  albumin  induced  mast  cell  degranulation  in  mice;  passive
cutaneous  anaphylaxis  in  rats  and  clonidine  induced  catalepsy  in  mice
respectively. ECGF at (100−150 mg·kg, i.p.) significantly protected egg albumin
induced degranulations of mast cells and caused reduction of blue dye leakage in
passive cutaneous anaphylaxis in dose dependently.  The treatment ECGF also
inhibited clonidine induced catalepsy in dose dependent manner. Phytochemical
studies  observed  presence  of  saponin,  steroids,  alkaloids,  flavonoids  and
glycosides. In conclusion ECGF possesses mast cell stabilizing; anti anaphylactic
and antihistaminic potential which might be used in treatment of asthma.
Afreen Ansari et al.19
In vivo models: Inhibition  of  histamine  induced  broncho constriction
by  various  doses  of  test  compound and  standard  is  recorded. ED50  values
for inhibition  in  pulmonary  resistance  (RL)  are calculated.  Furthermore, the
time course  of histamine  antagonism  can  be  evaluated. Compounds can be
tested either after IV injection of  histamine  (prevention)  or  during  intravenous
infusion of histamine (intervention).
M.S.Harisha et al.20
The  ethanolic  and  aqueous  extracts  of  the  whole  plant  of
S.orobanchioides were  evaluated  for  antihistaminic  and  mast  cell  stabilizing
activities. Both extracts inhibited histamine-induced contractions of the guinea-
pig ileum at the concentration range of 2.5– 25 g/ml in a dose-related manner. At
25g/ml,  both  extracts  inhibited  the  response  of  histamine  (0.5g/ml)  almost
completely.  The  effect  of  these  two  extracts  on  the  degranulation  rate  of
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sensitized peritoneal  cells  of  albino rats when challenged with antigen (horse
serum)  was  studied.  Triple  vaccine  was  used  as  adjuvant.  Ketotifen  and
prednisolone were used for comparison. The ethanolic extract at 100 and 200
mg/kg body weight was found to significantly inhibit degranulation of mast cells
to an extent of 52.143 and 67.963 respectively. At the same doses, the aqueous
extract  showed 42.092.91 and 60.673.50% reduction in degranulation of  mast
cells, respectively.
P. Venkatesh et al.21
Estimation of histamine release is key parameter for evaluating any target
for its anti-allergic potential. The stabilization potential of the alcoholic extract of
COR (100–400 mg/kg) against mast cell degranulation was studied on isolated
mice  peritoneal  mast  cells.  The  antihistaminic  activity  was  performed  by
determining the mortality rate of mice upon exposure to compound 48/80 and
effecton inhibition of histamine release upon degranulation. The raised number
of intact mast cells intimates that the COR stabilized the mast cell degranulation
(60.96±1.96%) and percentage antihistaminic potential of the extract (63.58±1.8
inhibition at dose of 400 mg/kg) and it virtues further work towards the isolation
of phytoconstituents from this plant. This finding provides evidence that COR
inhibits  mast  cell-derived  immediate-type  allergic  reactions  and  mast  cell
degranulation.
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4-AIM OF STUDY
Asthma is one of the common disorders encountered in clinical medicine
in both adults and children are asthma and it is characterized by inflammation of
the airways which causes airway dysfunction. 
Asthma is currently a worldwide problem with around 300 million people
around the global suffering from it and world deaths of about 25000 annually.
Inhaled bronchodilators and anti inflammatory drugs are available and effective
and they require long term use and are associated with side effects.
 This is why alternative and complementary medicine is being sort after
to prevent these side effects.
Several medicinal plants have anti inflammatory effect and have proved
effective in the treatment of asthma.
Clerodendrum  serratum Linn  (Family-Verbenaceae)  is  very  widely
distributed in tropical and subtropical regions of the world.
Citric acid, Acetylcholine, Histamine is mainly used for evaluating anti
asthmatic activity of particular drug. This review contains list of medicinal plant
which  have  been  tested  for  anti  asthmatic  activity  in  the  Citric  acid,
Acetylcholine induced asthmatic in Rat model
Thus, the information provided in this research will help the researchers
for the development of an alternative methods rather than inhalers and oral anti
asthmatic drugs for the treatment of asthma and COPD which will minimize the
complication.
Many plants obtained from the natural source play a significant role in
the health care system. 
Literature survey on herbal  drugs has shown significant anti  asthmatic
activity which has not shown any remarkable side effect. The pharmacological
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mechanism which the phyto constituents producing the anti asthmatic activity are
not clearly understood till date. The several herbal formulation have derived from
the Ayurveda, traditional system of Indian medicine  and its additional system of
medicine,  yet  to  be  scientifically  validated  that  they  have  exhibited
pharmacological action against Asthmatic. Only less number of scientific data of
traditional medicines is available for the treatment of Asthmatic.
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5-PLANT PROFILE 22,23,24
Synonym:  Rotheca serrata (L.) Steane & Mabb.
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5.1 CLASSIFICATION 22,23,24
Kingdom : Plantea
Class : Magnoliopsida 
Subclass : Lamiidae 
Order : Lamiales 
Family : Lamiaceae/ Verbenaceae 
Sub-family : Ajugoideae 
Genus : Clerodendrum 
Species : serratum 
5.2 VERNACULAR NAMES
English : Blue glory, Beetle killer 
Hindi : Bharangi 
Kannada : Gantubarangee 
Malayalam : Cheruthekku 
Sanskrit : Angaravalli, Padma, Brahmanayashtika, Barbura 
Tamil : Cheruteku 
Telugu: Ganttubrarangee 
Urdu : Bharangi, Baharangi
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5.3 DISTRIBUTION:
               Clerodendrum serratum Linn native to tropical and warm
temperate regions of the world,   with  most  of   the  species   occurring  in
tropical  Africa  and southern  Asia,  but  some  in  the  tropical Americas  and
northern Australia,  and  a  few  extending  north  into  the  temperate  zone  in
eastern Asia.
5.4 DESCRIPTION:
                         Clerodendrum  serratum  Linn (Verbenaceae).is  a  slightly
woody  shrub  with blunty  stems  and  branches.  These trees are about 2-8 ft
high.  It is annual or perennial, usually aromatic.
5.5 CHEMICAL CONSTITUENTS:
            Leaf extracts contains 
 Stigma sterol, 
 Α-spinasterol, 
 Luteolin, 
 Luteolin-7-0 glucuronide, 
 Apigenin, 
 Baicalin 
 Suctellarin 7-0 glucuronide.
5.6 PARTS USED: 
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  Fresh leaves, flowers and dried fruits, roots, seeds, stem, barks.
5.7 TRADITIONAL USE:
                                  Clerodendrum serratum as effective treatment against
asthma, bodyache, cholera, eye disorder, ulcers, snake-bite, wound, tuberculosis
and  epilepsy.  It  has  antibacterial,  antihistaminic,  hepatoprotective,  antipyretic,
antinociceptive and anti-inflammatory.
Root  is  pungent,  bitter,  acrid,  dry,  heating,  anti-inflammatory,  digestive,
carminative,  depurative,  expectorant,  antispasmodic,  stimulant,  appetizer  and
anthelmintic.
Leaves are used in fever and hiccough. Its boiled leaves are used in cephalgia
and opthalmia where as its boiled seeds in butter milk is used as aperients, in
dropsy and in catarrhal affection of lungs (Shah, 2003).
Clerodendrum  serratum,its  methnolic  extract  exhibit  significant  anticancer
activity  as  compared  to  aqueous  extract.  (Zalke  et  al.   2010).Antibacterial
activity of Clerodendrum serratum .L (Vidya S.Met al.  2010).
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6-PLAN OF WORK
Objectives:
The present study is to evaluate the anti asthmatic activities of Leaves in
Clerodendrum serratum Linn.
Step: 1
Plant collection and authentication of plant species.
Step: 2
Preparation of plant extracts.
• Aqueous extract of clerodendrum serratum. 
• Ethanolic extract of clerodendrum serratum.
Step: 3
• Evaluations of phytochemical constituents.
• Estimation of active constituents by TLC method.
Step: 4
Acute toxicity studies as per OECD guidelines.
Step: 5
Anti Asthmatic activity:
 Evaluation changes of lungs in asthmatic rats treated with Aqueous and
non aqueous extract of clerodendrum serratum and theophylline. 
Sacrifying animals and giving for Histopathological studies.
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7-MATERIALS AND METHODS
7.1 COLLECTION OF PLANT
         A novel approach to plant selection is a computerized selection method or
literature  information  selection  technique  (LIST)  that  correlates  biological
activity, botanical facts and chemotoxanomical information using NAPRALERT
database. Based on the literature review.,the plant was collected from eastern part
of  the  Ooty.  Clerodendrum  serratum is  a  small  tree  belonging  to  family
verbenaceae.  The  plant  was  taxonomically  identified  by  the  botanist
Dr.A.Balasubramanian,  ABS  Botanical  Conservation,  Research  and  Training
Centre KAARIPATTI, SALEM -636003 T.N., INDIA.
7.2 EXTRACTION OF PLANT 25,26,27
      The leaf of Clerodendrum serratum were shade dried at room temperature for
10 to 15 days. After shade drying of leaves, which was converted in to coarse
powder  form  by  using  the  mechanical  mixer.  Powdered  leaf  material  was
defatted using petroleum ether. Defatted plant material was extracted in soxhlet
apparatus.  Further  extract  with  90%  of  ethanol  and  concentrated  by  using
desiccators for the removal of remaining moisture.  The final  amount of solid
residue was 35% w/w.
7.3 CHEMICALS
 Ethanol 90%.
 Petroleum ether.
 Distilled water.
 Citric acid 0.1 mg/Spray.
 Acetylcholine 0.2 % /Spray.
7.4 DRUGS 28,29
 Theophylline 200mg/kg.
7.5 SOLVENTS
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Ethyl alcohol, Water, CMC (carboxy methyl cellulose)
7.6 PRELIMINARY PHYTOCHEMICAL STUDIES 30
                            The pharmacological and therapeutic action of crude drug is
determined  by the nature  of  its  constituents.   Thus the plant  species  may be
considered as a biosynthetic laboratory not only for the chemical compounds e.g.
carbohydrates,  proteins  and  fats  that  are  utilized  as  a  food  by  humans  and
animals, but also for a magnitude of compounds including alkaloids, flavonoids,
glycosides  etc.  which  exert  definite  physiological  effects.   These  chemical
compounds are responsible for the desired therapeutic properties.  To obtained
these pharmacological effects, the plant materials are used as such in their crude
from  or  may  be  extracted  with  suitable  solvents  to  take  out  the  deride
components and the resulting principle being employed as therapeutic agents.
By considering the above facts, it is necessary to evaluate the nature of extract
before evaluating the biological activity of same.  We have been selected such
extract  for  pharmacological  activity  which  contain  large  number  of  chemical
constituents.   Hence  for  this  purpose,  we  have  to  go  for  following  tests  to
evaluate the chemical nature of extracts qualitatively.
7.8 TESTS FOR CARBOHYDRATES AND GLYCOSIDES
A small quantity of the extracts was dissolved separately in 4ml of
distilled water and filtered.  The filtrate was subjected to various tests to detect
the presence of Carbohydrates.
Molisch’s Test
 Filtrate  was treated with 2-3 drops of  1% alcoholic  ∞- napthol
solutions  and 2ml of Con. Sulphuric acid was  added along the
sides of the test tube.  Appearance of brown ring at the junction of
two liquids shows the presence of carbohydrates.
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 Another portion  of the extract was hydrolysed with hydrochloric
acid  for  few  hours  on  a  water  bath  and  the  hydrolysate  was
subjected to Legal’s and Borntrager’s test to detect the presence of
different glycosides.
Legal’s Test
• To the  hydrolysate  I  ml  of  pyridine  and  few drops  of  sodium
nitropruside solutions were added and then it was made alkaline
with sodium hydroxide solution.  Appearance of pink to red colour
shows the presence of glycosides
    Bortanger’s Test:
• Hydrolysate  was  treated  with  choloroform  and  then  the
chloroform layer was separated.  To this equal quantity of dilute
ammonia  solution  added.   Ammonia  layer  acquires  pink  color,
showing the presence of glycosides.
TEST FOR ALKALOIDS
• A small portion of the solvent free alcohol and aqueous extracts
were stirred separately with few drops of dilute hydrochloric acid
and filtered.  The filtrate was tested with various reagents for the
presence of alkaloids.
• Mayer’s reagent - Cream ppt
• Dragendroff’s reagent  - Orange brown ppt.
• Harger’s reagent - Yellow ppt
• Wagner’s reagent - Reddish brown ppt
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TEST FOR PHYTOSTEROL
 The  extract  was  refluxed  with  solution  of  alcoholic  potassium
hydroxide  till  complete  saponification  has  taken  place.   The
mixture was diluted and extracted with ether.  The ether layer was
evaporated  and  the  residue  was  tested  for  the  presence  of
phytosterol.
Libermann Burchard Test
• The residue was dissolved in few drops of dil.  Acetic acid; 3 ml
of  acetic  anhydride was added  followed by few drops  of  Con.
Sulphuric  acid.   Appearance  of  bluish  green  color  shows  the
presence of phytosterol.
TESTS FOR FIXED OILS
Spot Test
• Small  quantities  of  various  extracts  were  separately  pressed
between two filter papers.  Appearance of oil stain on the paper
indicates the presence of fixed oil.  Few drops of 0.5N alcoholic
potassium  hydroxide  were  added  to  small  quantity  of  various
extracts along with a drop of phenolphthalein.  The mixture was
heated on a water bath for 1-2 hours.  Formation of soap or partial
neutralization of  alkali  indicates  the presence of  fixed oils  and
fats.
TEST FOR GUMS AND MUCILAGES
• Small quantities of the extracts were added separately to 25 ml of
absolute  alcohol  with  constant  stirring  and  filtered.   The
precipitate  was  dried  in  air  and  examined  for  its  swelling
properties for the presence of carbohydrates.
TEST FOR SAPONINS
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• The extract was diluted with 20ml of distilled water and it was
agitated in a graduated cylinder for 15 minutes.  The formation of
1cm layer of foam shows the presence of saponins.
TEST FOR PROTEINS AND FREE AMINO ACIDS
Small quantities of the extracts were dissolved in few ml of water
and treated with following reagents.
- Appearance of red color shows the presence of protein and free amino acid
- Appearance of purple color shows the presence of proteins and free amino
acid
- Equal  volumes  of  5% sodium hydroxide  solution  &  1% copper  sulphate
solution was added.
Appearance  of  pink  or  purple  color  shows  the  presence  of  proteins  and  free
amino acids.
TEST FOR PHENOLIC COMPOUNDS AND TANNINS.
Small quantities of the extracts were taken separately in water and
test for the presence of phenolic compounds and tannins was carried out with the
following reagents.
1. Dil. Ferric Chloride solution (5%) – Violet Color.
2. 1% solution of gelatin containing 10% sodium chloride – White ppt
3. 10% lead acetate solution – White ppt
TEST FOR FLVAVONOIDS
1. With Aqueous Sodium Hydroxide Solution
Blue to violet  color (anthocyanins) Yellow color  (flavones),  yellow to orange
(flavonones)
2. With Concentrating Sulphuric Acid
Yellow orange color (anthocyanins) yellow to orange color (flavones) orange to
crimson (flavonones)
3. Shinoda’s Test
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Small  quantities  of  the  extract  were  dissolved  in  alcohol,  to  them  piece  of
magnesium followed by Conc. Hydrochloric acid drop wise added and heated.
Appearance of magenta color shows the presence of flavonoids.
TLC METHOD
Aluminium  sheets  and  glass  backed  TLC  plates  were  used  for  the
isolation of compounds. The plates were divided in to size of 10 cm x 1.5 cm. A
light  pencil  was  drawn  1cm  from  the  bottom  and  top  edge  of  the
chromatographic plate. 6mg of column fraction sample was dissolved in 60 ml of
absolute methanol and placed as preparatory on two TLC plates (10x1.5 cm)
using a 10 micro litre of capillary which delivers approximately 10 microgram
spot on to the place until each plate contains 150 microgram and subsequently
placed in the eluting solvent. (Chloroform:methanol:water (5:4:1)) in a TLC tank
which was fill to a depth of 0.5 cm the solvent migrated upwards on to the TLC
plate until the pencil line drawn across the top edge (solvent front) was reached.
The plates were removed from the chamber and air dried. A portion of the plates
(1 cm) was cut  off  using a glass cutter  and sprayed with a  detecting reagent
(diphenyl ethantamine (glycosides)) in order to visualize the constituents on the
eluted plates after heating for three minutes at 110o c in on oven. The plates were
also visualized under UV light at 360 nm and 254 nm and the fluorescence (360
nm) or quenching (254 nm). Compounds were marked and the spot (layer) were
out lined with the pencil.
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Distance from origin to the point of maximum intensity
RF value =
Distance from origin to the solvent front
            
Sample 1: 5/7 = 0.7142.
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Sample 2: 4.7/7 = 0.6714.
Report
 The RF value of sample 1 and sample 2 were coinciding with standard values.
RF value for sample 1 = 0.7142
RF value for sample 2 = 0.6714.
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8-ACUTE ORAL TOXICITY STUDIES
8.1 PROCEDURE31
8.1.1 Preparation of animals
The animals are randomly selected, marked to permit individual identification,
and  kept  in  their  cages  for  at  least  5  days  prior  to  dosing  to  allow  for
acclimatisation to the laboratory conditions.
8.1.2 Preparation of doses
In general test substances should be administered in a constant volume over the
range  of  doses  to  be  tested  by  varying  the  concentration  of  the  dosing
preparation. Where a liquid end product or mixture to be tested however, the use
of the undiluted test substances, i.e. at a constant concentration, may be more
relevant to the subsequent risk assessment of the substances, and is a requirement
of some regulatory authorities.  In  either  case,  the maximum dose volume for
administration must not be exceeded.  The maximum volume of the liquid that
can  be  administrated  at  one  time  depends  on  the  size  of  the  test  animal.  In
rodents, the volume should not normally exceed 1ml/100 gm of body weight.
However  in  the  case  of  aqueous  solution  2ml/100  gm  body  weight  can  be
considered. With respect to the formulation the dosing preparation, by use of an
aqueous  solution/  suspension/  emulsion  is  recommended  wherever  possible,
followed in order of preference by solution/suspension/emulsion in oil ex. (Corn
oil)  possible  solution  in  other  vehicle.  For  vehicles  other  then  water  the
toxicological  characteristics  of  the  vehicle  should  be  known.  Doses  must  be
prepared shortly prior to administration unless the stability of the preparation
over  the  period  during  which  it  will  be  used  is  known  and  shown  to  be
acceptable.
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8.1.3 Administration of the dose
The  test  substance  is  administered  in  a  single  dose  by  gavages  by  using  a
stomach tube or suitable incubation cannula. In the unusual circumstance that a
single dose is not possible, the dose may be given in small fraction over period
not exceeding 24 hours. 
Animal should be fasted prior to dosing (e.g. with rat, food but not water should
be withheld over night, with the mouse food but not water should be withheld for
3-4 hours) following the period of fasting, the animal should be weighed and the
test substances is administered. After the substance has been administered, food
may be withheld for a further 3-4 hours in rats or 1-2 hours in mice. Where a
dose is administered infraction over a period it may be necessary to provide the
animals with food and water depending on the length of period.   
8.1.4 Number of the Animal and Dose Levels
Three animals are used for each step. The dose level to be used as the starting
dose is selected from one hour of four fixed levels, 5, 50, 300, 2000 mg/kg body
weight. The starting dose level should be that which is most likely to produce
mortality in some of the dosed animals. 
When available  information suggests  that  mortality is  unlikely at  the highest
starting  dose  level  (2000  mg/kg  body  weight),  then  a  limit  test  should  be
conducted. When there is no information on a substance to be tested, for animal
welfare  reasons  it  recommended  using  the  starting  dose  of  300  mg/kg  body
weight.
The time interval between treatment groups is determined by the onset, duration,
and severity of  toxic signs.  Treatment  of  animals  at  the next dose should be
delayed until one is confident of survival of the previously dosed animals.
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Exceptionally, and only when one justified by specific regularity needs the use of
additional upper dose level  5000 mg/kg body weight may be considered. For
reason of animal welfare concern, testing of animals in GHS category 5 ranges
(2000 – 5000 mg/kg) is discouraged and should only be considered and when
there is a strong likelihood that results of such a test have direct relevance for
protecting human or animal health or the environment.
8.1.5 Limit test:
The  limit  test  is  primarily  used  in  situations  where  the  experimenter  has
information indicating that the test material is likely to be nontoxic, i.e., having
toxicity only above regulatory limit doses. Information about the toxicity of the
test material can be gained from knowledge about similar tested compounds or
similar tested mixtures are products, taking into consideration the identity and
percentage of components known to be toxicological significance.
    A limit test at one dose level of 2000 mg/kg body weight may be carried out
with six animals (3 animals per step). Exceptionally a limit test at one dose level
of  5000  mg/kg  may be  carried  out  with  3  animals.  If  test  substance-related
mortality is  produced,  further  testing at  the next  lower level  may need to  be
carried out.
8.1.6 Test report:
• Tabulation of response data and dose level for each animal (i.e. animal showing
signs  of  toxicity  including  mortality;  nature,  severity,  and  duration  of  side
effects);
• Tabulation of body weight and body weight changes;
• Individual weights of animals at the day of dosing, in weekly intervals thereafter,
and at the time of death or sacrifice;
• Date and time of death if prior to scheduled sacrifice;
• Time course of onset of signs of toxicity, and whether these were reversible for
each animals;
• Necropsy findings and histopathological findings for each animal.
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9-SCREENING METHODS FOR ANTI ASTHMATICS
9.1 ANIMALS
Adult male albino rats, weighing 150 – 200 g were used for the present
study. Animals were acclimated for 15 days in our disease free animal house
prior  to  the start  of  the experiment.  The animals were  kept  in  clean and dry
plastic cages, with 12 h light: 12 h dark cycle at 25+20 c temperature and 45 –
60% relative  humidity.  Animals  were  given  free  access  to  standard  feed  and
water and libitum. For experimental purpose the animals were kept on overnight
fasting  but  allowed  free  access  to  water.  The  research  conducted  under  the
guidelines of CPCSEA and approved by  Institutional Animal Ethics Committee
in ref. No. M.Pharma/2013/09.
INVIVO METHOD32,33,34,35
9.2 EXPERIMENTAL DESIGN – I36,37,38,39
Overnight fasted Rats were divided into six groups
1. Inducer control (IC) = Acetylcholine + Citric acid (0.2% spray),
2.  STD received Theophylline (200 mg/kg) 
3. AECS (100mg/kg) (200mg/kg),
4.  NAECS (200mg/kg) (400mg/kg),p.o. Bronchospasm was induced in
rats by exposing them to Acetylcholine & Citric acid (0.2% spray) produced by an
ultra sound nebulizer in an aerosol chamber (24*14*24 cm) made of Perspex glass.
The  time  required  for  appearance  of  pre  convulsive  dyspnoea  caused  by  the
Acetylcholine & Citric acid (0.2% spray) was recorded for each animal. Prior to
drug  treatment,  each  animal  was  placed  on  Histamine  chamber  and  exposed  to
Acetylcholine + Citric acid 0.2% aerosol. The preconvulsive time (PCT), i.e the time
of  aerosol  exposure  to  the  onset  of  dyspnoea  leading  to  the  appearance  of
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convulsion, was noted. As soon as the preconvulsion dyspnoea (PCD) was noted, the
animals were removed from the chamber and placed in fresh air to recover as basal
value. Rats were then allowed to recover from dyspnoea for 24 hrs. After 24 hrs, the
animals of STD received Theophylline (200 mg/kg), AECS (100mg/kg) (200mg/kg),
NAECS  (200mg/kg)  (400mg/kg).  These  animals  were  again  subjected  to
Acetylcholine + Citric acid 0.2% aerosol later at an interval of 1hr, 4hrs, and 24 hrs
to determine preconvulsion time (PCT). The protection offered by the treatment was
calculated by using the following formula 
Percentage protection = (1 – T1/T2) * 100
Where, T1 = the mean of PCT before administration of test drugs, and
T2 = the mean of PCT after administration of test drugs at 1 hr, 4 hrs and
24 hrs.
9.3 STATISTICAL ANALYSIS
All the values were expressed as mean +
-   
SEM. The results were analyzed
for statistical significance by using one-way ANOVA followed by Dunnett’s test.
P<0.05 was considered significant.
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INVITRO METHOD
9.4 INDUCTION OF ASTHMA40,41,42,43,44
Asthma was induced by citric acid 0.1 mg and acetylcholine 0.2 mg in the
form of spraying in alternative days for two weeks. The extract of c.serratum and
Theophylline was administered by oral route for two weeks. At the end of the
treatment, all of the rats were sacrificed and Lungs Blood Samples were taken
out, fixed then histopathological studies were followed.
9.5 EXPERIMENTAL DESIGN – I
24 male adult rats were randomly divided into 6 groups:
 Asthma group received a normal diet (A)
 Asthma group treated with Theophylline (200 mg/kg b.w.) (T)
 Asthma group which received AECS (100 mg/kg b.w.) (P1)
 Asthma group which received AECS (200 mg/kg b.w.) (P2)
 Asthma group which received NAECS (200 mg/kg b.w.) (E1)
 Asthma group which received NAECS (400 mg/kg b.w.) (E2)
9.6 PARAMETERS FOR INVESTIGATION
The other major type of  blood cells are the white blood cells (WBC’s), which
are also referred to as leukocytes. There are many more RBC’s than there are
WBC’s. For every leukocyte present in a sample there will normally be 600 to
700 RBC’s. The major role of the white blood cells is to defend the body against
invading organisms such as bacteria, viruses, and fungi. There are different types
of leukocytes, and a white blood count (WBC) is a total of all the various kinds.
The normal range for a  WBC count in the dog would be between 6,000 and
17,000 per microliter, and in the cat, 4,900-20,000/µ  l. The number of WBC's is
typically elevated when the body is fighting a severe infection or stressed by
metabolic  toxins  (a  patient  that  was  in kidney  failure  with  waste  products
building up in its body would normally have an elevated WBC). In  addition,
when extremely excited (if we overly excite or frighten the animal when drawing
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the blood sample) white blood cells will be released into the blood and the levels
will  rise.  The WBC count  will  be lower than normal,  if  an animal  has  been
weakened from a prolonged, debilitating disease and in some viral infections.
WBC’s are divided into two groups depending on how they react to the stains
that are used to better observe them under a microscope. There are granulocytes
(they are WBC's with granules that absorb the stain) and the agranulocytes (those
that  do  not  absorb  the  stain).  The  granulocytes  include  the  neutrophils,
eosinophils, and the basophils, while the agranulocytes are the lymphocytes and
monocytes
9.7 HISTOPATHOLOGICAL EXAMINATION45,46,47,48
After 14 days experimental period and the last blood sampling, the whole
Lungs were removed after sacrificing the animal and were fixed in 10% formalin
for histopathological examination. Sections were cut and stained by hematoxylin
and eosin (H&E) for histological examination.
9.8 STATISTICAL ANALYSIS
All the values were expressed as mean +
-   
SEM. The results were analyzed
for statistical significance by using one-way ANOVA followed by Dunnett’s test.
P<0.05 was considered significant.
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10-RESULTS AND DISCUSSIONS
Table-2
10.1  PHYTOCHEMICAL CONSTITUENTS  OF DIFFERENT
EXTRACTS OF LEAVES OF CLERODENDRUM SERRATUM
(+)  → Positive
(-)  → Negative
10.2 DATA SHOWING   ACUTE ORAL TOXICITY FOR AECS53
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Constituents
Aqueous
extract
Non
aqueous
extract
Carbohydrates - -
Glycosides - -
Alkaloids - -
Flavonoids + +
Phenols + +
Fixed oils - -
Steroids + +
Saponins - -
Gums  &
mucilage - -
Proteins  &
free  amino
acids
- -
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10.4 PRE CONVULSION DYSNOPEA55,56,57,58,59
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TREATMEN
T DOSE BEFORE 1 Hr
4
Hrs
24
Hrs
Negative
control
Ach + 
Citric 
acid
18.2 +
2.2739
18.2 +
0.125
0
17.4 +
0.091
17.2
+
0.11
0
Positive
control
Ach +
Citric
acid +
Theophy
lline
18.2 +
0.1250
55.8 +
1.315
64.3 +
1.548
**
34 +
1.47
2**
AECS 100
mg/kg
17.5 +
0.1371
41 +
1.291
43 +
1.291
22.8
+
0.47
8
AECS 200
mg/kg
17.5 +
0.2955
57.8 +
1.750
59.8 +
1.750
**
33 +
1.22
5**
NAECS 200
mg/kg
18.0 +
0.4328
38.3 +
1.250
40 +
1.250
21.8
+
0.47
8
NAECS 400
mg/kg
17.5 +
0.5282
40 +
1.291
41.5 +
1.258
27.1
+
0.31
4
          Values are represented as mean ± S.E.M (n=6)
   One-way ANOVA followed by Student-Newman-Keuls post test (P< 0.001)
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The Ach + Citric acid induced asthma in rats, results have expressed on Table. All
the  groups  of  animals  were  affected  in  asthma,  which  indicated  PCD  were
constantly increased, the aqueous extract of c.serratum 100 & 200 mg/kg and non
aqueous  extract  of  c.serratum treated  groups  200  &  400  mg/kg  were  dose
dependent manner decreased (P<0.001)**&  (P<0.0001)*** (59.8 + 1.750**↓&33
+ 1.225**↓), (41.5 + 1.258↓ & 27.1 + 0.314↓) .When compared  with control group
but  positive  control  have  more  anti  asthmatic  activity   (P<0.001)**&
(P<0.0001)*** When compare to each groups of aqueous extract of c.serratum 200
mg/kg have equipotent activity (59.8 + 1.750**↓&33 + 1.225**↓). When compared
with positive control. The aqueous extract of c.serratum 100&200 mg/kg have been
expressed more anti asthmatic action (98.6±1.319↓ & 53.8±0.979↓) (P<0.001) **&
(P<0.0001) *** When compared to non aqueous extract of c.serratum groups. 
Page 52
RESULTS AND DISCUSSIONS
Before
0
5
10
15
20
GROUPS
Se
c
Page 53
RESULTS AND DISCUSSIONS
1Hr
0
20
40
60
80
GROUPS
Se
c
Page 54
RESULTS AND DISCUSSIONS
4 Hrs
0
20
40
60
80
GROUPS
Se
c
Page 55
RESULTS AND DISCUSSIONS
24 Hrs
0
10
20
30
40
GROUPS
Se
c
Page 56
RESULTS AND DISCUSSIONS
10.5 ANTI ASTHMATIC ACTIVITY60,61,62,63,64
Normal NegativeControl
Positive
Control
AECS 100
mg/kg
AECS 200
mg/kg
NAECS
200 mg/kg
NAECS
400 mg/kg
1.33 +
0.333
13.66 +
0.881
6.33 +
0.881** 8 + 0.577
2 +
0.577** 10 + 0.577
8.33 +
0.333
               Values are represented as mean ± S.E.M (n=6)
      One-way ANOVA followed by Student-Newman-Keuls post test (P< 0.001)
The effect of Aq. and Non Aq. extract of  c.serratum Eosinophils on indicated in
Table,  which is  correlated to  anti  asthmatic  action. After  the Ach + Citric  acid
treatment, on day 15 all the groups of animal Eosinophils levels were significantly
decreased  (13.66  + 0.881↑,  6.33  + 0.881**↓,  8  + 0.577,  2  + 0.577).  The
Eosinophils levels were significantly dose dependent manner decreased, after the
treatment of Aq. and Non Aq. extract of c.serratum 100, 200 & 200, 400 mg/kg (8
+ 0.577, 2 + 0.577**↓, 10 + 0.577,  8.33 + 0.333) *** at 15 th day.
 On day 15th the Aqueous extract of c.serratum treated groups 100 & 200 mg/kg
were  Eosinophils  levels  were  more  significantly  decreased  (P<0.001)  **  &
(P<0.0001)*** when compared  with Non Aq. extract of c.serratum. The Aqueous
extract  of  c.serratum 200 mg/kg have  equipotent  activity (2  + 0.577**↓)  when
compared with Normal group (1.33 + 0.333). 43,44,45,46,47
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10.6 HISTOPATHOLOGICAL REPORT
Figure: 1 Control group
Figure: 2 Control group
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IMPRESSION:
The alveoli thickness is normal so free of haemorrhage.
Figure: 3 Negative Control group
Figure: 4 Negative Control group
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IMPRESSION:
Alveolar wall appears thickened in most of the areas when 
compared to control group.
Figure: 5 Positive Control group
Figure: 6 Positive Control group
IMPRESSION:
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Alveolar wall thickness appears normal in both lungs.
Figure: 7 Aq.Extract 100 mg/kg Treated group
IMPRESSION:
Minimal thickening of the alveolar walls when compared to Control 
group.
Figure: 8 Aq.Extract 200 mg/kg Treated group
IMPRESSION:
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No more thickening of the alveolar walls when compared to Control 
group.
Figure: 8 Non Aq.Extract 200 mg/kg Treated group
IMPRESSION:
More thickening of the alveolar walls when compared to Control group 
and slightly less thickening walls when compared to Negative control group.
Figure: 8 Non Aq.Extract 400 mg/kg Treated group
IMPRESSION:
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Minimal thickening of the alveolar walls when compared to Control 
group.
DISCUSSIONS
 Asthma is common respiratory disease. The morbidity and the mortality
of  the  disease  is  increasing  and  making  a  global  concern.  The  syndrome of
bronchial asthma is characterized by wide spread narrowing of the bronchial tree
due to contraction of the smooth muscle in response to multiple stimuli resulting
in the release of chemical mediators such as Ach and Citric acid.  In the presence
study c.serratum..... Significantly inhibited the Ach and Citric acid induced anti
asthmatic properties of the plant.
Ach and Citric acid induced Bronchoconstriction is the traditional
immunological model of the antigen induced air way obstruction. Ach and Citric
acid when inhaled causes hypoxia and leads to convulsion in rats and causes very
strong smooth muscle contraction, profound hypotension, capillary dilation in
cardio vascular system a prominent effect caused by histamine leads to severe
Bronchoconstriction in rats that causes asphyxia and death. Bronchodilator can
delay the occurrence of these symptoms. The results of the study confirmed the
bronchodilator  properties  of  the  plant,  justifying  its  traditional  claim  in  the
treatment of asthma.
Drugs  effective  in  the  asthma  are  mostly  steroidal  and  also
flavonoids  in  nature.  Phytochemical  profile  of  the  plant  reveals  the  presence
flavonoids  (Apigenin),  steroidal  nucleus  (α-spinasterol)  in  the  form  of
triterpenoids. The anti asthmatic activity showed by leaves of the plant extract
(Apigenin and α-spinasterol) may be because of the chemical moieties. However
this  claims demands for  further  research and studies are in fact  underway to
isolate and characterized the active principles responsible for the anti asthmatic
activity.
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On the basis of the result in these experiments, this may be stated that the
aqueous extract of  Clerodendrum serratum 200mg/kg has a beneficial effect in
asthmatic patients. It will reduce the alveolar thickness and Eosinophils counts
in blood further studies are required to purify the active principle and to study the
molecular mechanism of the exact pathway. 
Non  aqueous  extract  of  Clerodendrum  serratum  (400mg/kg)  having
fewer amounts of steroids and flavonoids because it will filter the all compounds
and reduce the quantity of chemical moieties.
But  aqueous  extract  of  Clerodendrum  serratum  (200mg/kg)  having
higher  amount  of  chemicals  when  compare  to  Non  aqueous  extract  of
Clerodendrum serratum (400mg/kg) so it will produce anti asthmatic at equal to
standard drug.
In lungs alveolar thickness reduced by the AECS 200mg/kg as equal to
standard drug and also it’s same as normal lungs.
So aqueous  extract  of  Clerodendrum serratum  having good beneficial
effect for the asthmatic patients.
This  information’s  will  be  useful  for  the  development  of  alternative
method rather  than  anti  asthmatic  agents  (Inhalers,  Tablets,  Injections,  Nasal
sprays, Respules) for the treatment of Asthmatic patients. This will minimize the
wheezing and or asthmatic symptoms.
Page 64
BIBLIOGRAPHY
12-BIBLIOGRAPHY
1. 1. The U.S. Food and Drug Administration, Center for food safety and Applied
Nutrition. Economic Characterization of the Dietary Supplement Industry Final
Report. 1999
2. Barz, W. and Ellis, E. 1981. Potential of plant cell cultures for pharmaceutical
production.  In  Natural  products  as  medicinal  agents.  (eds.)  Beal,  J.L.  and
Reinhard,  E. Suppl. to Planta Medica, Hippokrates Verlag,  Stuttgart. pp 471-
508.
3. Cassady, J.M., Chang, C.-J. and McLaughlin, J.E. 1981. Recent advances in the
isolation and structural elucidation of antineoplastic agents in higher plants. In
Natural products as medicinal agents. (eds.) Beal, J.L. and Reinhard, E. Suppl.
Planta Medica. Hippokrates Verlag, Stuttgart. pp 93-124.
4. Compadre,  C.M.,  Pezzuto,  J.M.,  Kinghorn,  A.D.  and  Kalmath,  S.K.  1985.
Hernandulcin: An  intensely sweet compound discovered by review of ancient
literature. Science, 227: 417-419
5. Wall,  M.E.  and  Wani,  M.C.  1981.  Structure  activity  relationship  of  plant
antitumour  agents  related  to  camptothecin  and  the  quassinoids.  In  Natural
products as medicinal agents. (eds.) Beal, J.L. and Reinhard, E. Suppl. Plants
Medica. Hippokrates Verlag, Stuttgart. pp 125-149.
6. Wermuth, C.-G. 1981. Modulation of natural products in order to improve their
pharmacokinetic  properties.  In  Natural  products  as  medicinal  agents.  (eds.)
Beal, J.L. and Reinhard, E. Suppl. Planta Medica. Hippokrates Verlag, Stuttgart.
pp 185-215
7. Singh  Amrit  pal,  Promising  Pytochemicals  from  Indian   medicinal  plants,
Ethanobotanical leaf lets 9:15-23, 2005
8. Naranjo P., The urgent need for the study of medicinal plants. In Ethnobotany:
Evolution of a discipline. (Eds.) Schultes, R.E., and Reis, S.von., Chapman &
Hall, London.,1995: 362-368
9.  Pearce D, The economic value of biodiversity, Earthscan Publication, London,
1994: 101-102
Page 65
BIBLIOGRAPHY
10. Barz, W., Ellis, E.Potential of plant cell cultures for pharmaceutical production.
In Natural products as medicinal agents. Beal, J.L., and Reinhard, E., Suppl. to
Planta Medica, Hippokrates Verlag, Stuttgart., 19801:471-508
11. Kameswara Rao, C., Sangeetaa, W. Alternate sweeteners. Vatika, No.4, Winter,
1993: p.193
12. Ralph  W.  Moss,  Ph.D  Galen  on  Cancer-  How  Ancient  Physicians  Viewed
Malignant Disease 1989 Speech.
13. Jemal A. Murray T, Ward E, Samuels A, Tiwari R C, Ghafoor A, Feuer EJ, Thun
MJ(2005). “Cancer statistics, 2005”. CA Cancer J Clin 55(1): 10-30.
14. The Basic Science of Oncology. Tannock IF, Hill RP et al 4th ed.2005 McGraw-
Hill
15. Matoba S, Kang J, Patino W, Wragg A. Boehm M, Gavrilova O, Hurley P, Bunz
F,  Hwang  P  (2006).  “p53  regulates  mitochondrial  respiration”.  Science
312(5780):1650-3
16. Harsha Mohan, Neoplasia, Text book of pathophysiology, 10th edition, 706
17. Lanier AP, Cancer and stilberstrol:  a follow- up of 1179 persons exposed in
utero and bron 1943-1959. Mayo Clinic Proceeding, 1973; 48:793-799
18. Principles  of  Cancer  Biology.  Kleinsmith,  LJ  (2006).  Pearson  Benjamin
Cummings
19. Goodman  and  Gillman,  The  Pharmacological  Basis  of  Life,  10th edition,
2001:1381-1385
20.   Harper et al, “Efficacy of a bivalent L1 virus like particle vaccine in prevention
of infection with human papillomavirus types 16 and 18 in young women: a
randomized controlled trial”. Lancet364(9447): 1757-65
21. Fearson  E  R,  Vogelstein  B,  A genetic  model  to  colorectal  carcinogenesis,
Cell,61(1990), Page-759
 Trease & Evans. Pharmacognosy, 14th Edition, Published by Harcourt Brace &
company asia PTE LTD 1996.
2. Biren Shah & A.K.Seth, Text book of Pharmacognosy & Phytochemistry, 1st
Edition, Reed  Elsevier India Pvt. LTD, 2010.
3.  Lippincott’s  Illustrated  Reviews,  Pharmacology  14th  Edition,  South  Asian
Edition 2010.
Page 66
BIBLIOGRAPHY
4.  Goodmann  &  Gilman.  The  pharmacological  basis  of  therapeutics,  10th
International  edition, McGraw Hill publication, 2001:1687.
5. Conceptual Pharmacology by jagadish Prasad University press 2010.
6.  Clerodendrum  serratum:  A clinical  approach  Mukesh  Kr.  Singh,  Gaurav
Khare,  Shiv Kr.  Iyer,  Gotmi  Sharwan and  D.  K.  Tripathi  Journal  of  Applied
Pharmaceutical Science 02 (02); 2012: 11-15.
7.  Clerodendrum Serratum.(L) :  Traditional  Uses And Recent  Findings About
Authors:  Jatin  Sharma,  Dharmendra  kumar{Sr.  Lecturer},  Amarjeet  Singh
School of Pharmaceutical Sciences Shobhit University,Meerut.
8.  Clerodendrum and  Heathcare:  An Overview Neeta Shrivastava  Tejas  Patel
Medicinal and Aromatic Plant Science and Biotechnology ©2007 Global Science
Books.
9.  Histophatologic  changes  of  lung  in  asthmatic  male  rats  treated  with
hydroalcoholic  extract  of  plantago  majorand  theophylline  Farah  Farokhi,
Fereshteh Khaneshi Received: Sep 2, 2012; Accepted: Nov 25, 2012 Epub ahead
of print.
10. Histological Changes in Tissues of Trachea and Lung Alveoli of Albino Rats
Exposed  to  the  Smoke  of  Two  Types  of  Narghile  Tobacco  Products  Ziad
Shraideh and Hossam N. Najjar Volume 4, Number 4, December  2011 ISSN
1995-6673 Pages 219 – 224.
11.  Antiasthmatic  activity  of  aqueous  extract  of  pistacia  integerrima  galls
surendra  adusumalli  ,  pusapati  madan  ranjit,  m.sankaranarayan  harish
international journal of pharmacy and pharmaceutical sciences issn- 0975-1491
vol 5, suppl 2, 2013.
Page 67
BIBLIOGRAPHY
12.  Beneficial  Effect  of  Achyranthes  apseraLinn.  In  Toluene-Di-Isocyanate
Induced Occupational Asthma in Rats Bhoomika R. Goyal, Ramesh K. Goyal
and Anita A. Mehta. 
13. Micropropagation of Clerodendrum serratum L. Through Direct and Indirect
Organogenesis S.M. Vidya*, V. Krishna 1, B.K. Manjunatha 2 and  Pradeepa
Plant Tissue Cult. & Biotech. 22(2): 179-185, 2012 (December).
14. Effects of Fish oil and Dexamethasone inExperimentally-Induced Bronchial
Asthma Abeer A.A. Salama,Hala F. Zaki,Siham M. El-Shenawy, EL-Denshary,
E.S.M.,Ismaiel ElKassaby Ismaiel and Nermeen M. Shaffie Australian Journal of
Basic and Applied Sciences, 6(13): 497-506, 2012 ISSN 1991-8178.
15. Antiasthmatic effect  of  roots of  clitorea ternatea  linn.  Neelmani  chauhan,
saurabh rajvaidhya, b.k. Dubey chauhan et al., ijpsr, 2012; vol. 3(4): 1076-1079
issn: 0975-8232 available online on www.ijpsr.com    1076 ijpsr (2012), vol. 3,
issue 04
16.  Mast  cell  stabilizing  and  antiallergic  activity  of  Abrus  precatoriusin  the
management  of  asthma  DJ  Taur,  RY Patil  Asian  Pacific  Journal  of  Tropical
Medicine (2011)46-49
17.  Bronchodilatory  and  mast  cell  stabilising  activity  of  Cressa
creticaL.evaluation through in vivoand in vitroexperimental models Priyashree
Sunita,  SJha,  Shakti  Prasad  Pattanayak. Asian  Pacific  Journal  of  Tropical
Medicine (2012)180-186.
18.  Mast  Cell  Stabilizing,  Antianaphylactic  and  Antihistaminic  Activity  of
Coccinia grandisFruits in Asthma Dnyaneshwar J Taur, Ravindra Y Patil, Chinese
Journal  of  Natural  Medicines  2011,  9(5):  0359−0362doi:
10.3724/SP.J.1009.2011.00359.
19. In- vitro and In- vivo Models for Evaluation of Anti-Asthmatic Activity A
Review Afreen Ansari, P. Kashyap, H. Sawarkar, V. Deshmukh, A.Upadhyay, S.
Pal.
Page 68
BIBLIOGRAPHY
20.  Antihistaminic  and  mast  cell  stabilizing activity  of  Striga  orobanchioides
M.S.Harish,  Mallikarjun  Nagura,  Shrishailappa  Badam  53.  Mitra  SK,
Gopumadhavan  S,  Mohamed  R,  Venketaranganna  MV.  Antihistaminic   and
antianaphylactic  activity  of  HK-07,  a  herbal formulation. Indian Journal of
Pharmacology 2005; 37: 300-303.
21.Mast  cell  stabilization  and  antihistaminic  potentials  of  Curculigo
orchioidesrhizomes  P.  Venkatesh,  Pulok  K.  Mukherjee,  Satheesh  Kumar  N,
Neelesh  K.  Nema,A.  Bandyopadhyay,  Hiroyuki  Fukui,  Hiroyuki  Mizuguchi
Journal of Ethnopharmacology126 (2009) 434–436.
22.  Clerodendrum serratum:  A clinical  approach  Mukesh  Kr.  Singh,  Gaurav
Khare,  Shiv Kr.  Iyer,  Gotmi  Sharwan and  D.  K.  Tripathi  Journal  of  Applied
Pharmaceutical Science 02 (02); 2012: 11-15.
23. Clerodendrum Serratum.(L) : Traditional Uses And Recent Findings About
Authors:  Jatin  Sharma,  Dharmendra  kumar{Sr.  Lecturer},  Amarjeet  Singh
School of Pharmaceutical Sciences Shobhit University,Meerut.
24.  Clerodendrum and Heathcare: An Overview Neeta Shrivastava Tejas Patel
Medicinal and Aromatic Plant Science and Biotechnology ©2007 Global Science
Books.
25.  Antiasthmatic  activity  of  aqueous  extract  of  pistacia  integerrima  galls
surendra  adusumalli  ,  pusapati  madan  ranjit,  m.sankaranarayan  harish
international journal of pharmacy and pharmaceutical sciences issn- 0975-1491
vol 5, suppl 2, 2013.
26.  Chronic  Anti-Inflammatory  Activity  of  Ethanolic  Extract  of  Leaves  of
Clerodendrum viscosum by Carrageenin Induced Paw Oedema in Wistar Albino
Rats Chandrashekar R.and S. N. Rao British Journal of Pharmaceutical Research
3(4): 579-586, 2013 SCIENCEDOMAIN international.
Page 69
BIBLIOGRAPHY
27.  Clerodendrum and Heathcare: An Overview Neeta Shrivastava Tejas Patel
Medicinal and Aromatic Plant Science and Biotechnology ©2007 Global Science
Books.
28.  Histophatologic  changes  of  lung  in  asthmatic  male  rats  treated  with
hydroalcoholic  extract  of  plantago  majorand  theophylline  Farah  Farokhi,
Fereshteh Khaneshi Received: Sep 2, 2012; Accepted: Nov 25, 2012 Epub ahead
of print.
29.  Bronchodilatory  and  mast  cell  stabilising  activity  of  Cressa
creticaL.evaluation through in vivoand in vitroexperimental models Priyashree
Sunita,  SJha,  Shakti  Prasad  Pattanayak. Asian  Pacific  Journal  of  Tropical
Medicine (2012)180-186.
30. Trease GE, Evans WC. A Text book of Pharmacognosy. London; Bailliere
Tindall and Company Publishers; 1983.p. 343-83.
31.  OECD;  guidelines 425. Acute oral toxicity. Enviromental health and safety
monograph series on testing and assessment.2000.p. 24.
32. Englert   CE,  Wirth  K,  Gehring  D,  Fürst   U, Albus  U,  Scholz  W,
osenkranz  B, Schölkens  BA.  Airway  pharmacology  of the  potassium  channel
opener,   HOE   234,  in  guinea  pigs:   in  vitro   and  in  vivo  studies.  Eur  J
Pharmacol, 1992; 210: 69–75.
33. In- vitro and In- vivo Models for Evaluation of Anti-Asthmatic Activity A
Review Afreen Ansari, P. Kashyap, H. Sawarkar, V. Deshmukh, A.Upadhyay, S.
Pal.
34. Murphy DJ,  Joran  ME,  Renninger  JE. Effects of adenosine agonists and
antagonists  on  pulmonary  ventilation  in conscious rats. Gen Pharmacol, 1993;
24: 943–954. International Journal of Herbal Drug Research, Vol I, Issue 1, 19-
27, 2011. Journal of Ethnopharmacology 76 (2001) 197– 200.
35.  Antihistaminic  and  mast  cell  stabilizing activity  of  Striga  orobanchioides
M.S.Harish,  Mallikarjun  Nagura,  Shrishailappa  Badam  53.  Mitra  SK,
Page 70
BIBLIOGRAPHY
Gopumadhavan  S,  Mohamed  R,  Venketaranganna  MV.  Antihistaminic   and
antianaphylactic  activity  of  HK-07,  a  herbal formulation. Indian Journal of
Pharmacology 2005; 37: 300-303.
36.  Evaluation  of  antiasthmatic  and  antianaphylactic  activity  of  balanites
aegyptiaca (delile), (balanitaceae)savita d. Patil, sameer v. Ahale, sanjay j. Surana
asian journal of pharmaceutical and clinical research vol. 4, issue 1, 2011     issn
- 0974-2441.
37. Baruah, M.C.C., Gupta, P.P., Amar, N., Patnaik, G.K., Dhawan, B.N., 1998.
Antiallergic  and  anti-anaphylactic  activity  of  Picroliv–a  standardised  iridoid
glycoside fraction ofPicrorhiza kurroa. Pharmacology Research 38, 487–492.
38.Mast  cell  stabilization  and  antihistaminic  potentials  of  Curculigo
orchioidesrhizomes  P.  Venkatesh,  Pulok  K.  Mukherjee,  Satheesh  Kumar  N,
Neelesh  K.  Nema,A.  Bandyopadhyay,  Hiroyuki  Fukui,  Hiroyuki  Mizuguchi
Journal of Ethnopharmacology126 (2009) 434–436.
39. Gupta RK & Tandon V, An experimental evaluation of anticonvulsant activity
of  V.negundo, proceeding of 48th  annual conference, Dec 17-20, 2002 in CME
programme in physiology and pharmacology, Lucknow (abstract), In:  Indian J
Physiol Pharmacol, 2002, 46 (5S), 82.
40.  The Role  of  Mast  Cells  in  Citric  Acid-Induced  Airway Constriction  and
Cough Yih-Loong Lai,  Li-Ling  Wu,  Tai-Yin  Lin,  and  Chien-He Lin  Chinese
Journal  of  Physiology  52(5  Supplement):  332-338,  2009  DOI:
10.4077/CJP.2009.AMH079.
41.  Histophatologic  changes  of  lung  in  asthmatic  male  rats  treated  with
hydroalcoholic  extract  of  plantago  majorand  theophylline  Farah  Farokhi,
Fereshteh Khaneshi Received: Sep 2, 2012; Accepted: Nov 25, 2012 Epub ahead
of print.
42.  Antiasthmatic effect  of  roots of  clitorea ternatea  linn.  Neelmani  chauhan,
saurabh rajvaidhya, b.k. Dubey chauhan et al., ijpsr, 2012; vol. 3(4): 1076-1079
Page 71
BIBLIOGRAPHY
issn: 0975-8232 available online on www.ijpsr.com    1076 ijpsr (2012), vol. 3,
issue 04
43.  Bronchodilatory  and  mast  cell  stabilising  activity  of  Cressa
creticaL.evaluation through in vivoand in vitroexperimental models Priyashree
Sunita,  SJha,  Shakti  Prasad  Pattanayak. Asian  Pacific  Journal  of  Tropical
Medicine (2012)180-186.
44. Fuchs  J.,  Milbradt  R.  Skin  Anti-inflammatory  Activity  of Apigenin-7-
Glucoside in Rats. J Arzneimittelforschung. 1993; 3: 370-372.
42. Histological Changes in Tissues of Trachea and Lung Alveoli of Albino Rats
Exposed  to  the  Smoke  of  Two  Types  of  Narghile  Tobacco  Products  Ziad
Shraideh and Hossam N. Najjar Volume 4, Number 4, December  2011 ISSN
1995-6673 Pages 219 – 224.
46.  Mast  Cell  Stabilizing,  Antianaphylactic  and  Antihistaminic  Activity  of
Coccinia grandisFruits in Asthma Dnyaneshwar J Taur, Ravindra Y Patil, Chinese
Journal  of  Natural  Medicines  2011,  9(5):  0359−0362doi:
10.3724/SP.J.1009.2011.00359.
47. Al-Safi S, Ayoub N, Albalas M, Al-Doghim I and Aboul-Enein F. 2009. Does
shisha smoking affect blood pressure and heart rate. J of Public Health, 17:121-
126.
48. Onder  M,  Oztas  M  and  Arnavut  O.  2002.  Nargile  (HubbleBubble)
smoking-induced  hand  eczema.  Inter  J  of  Dermatol, 41:771-772.
49.  Clerodendrum and Heathcare: An Overview Neeta Shrivastava Tejas Patel
Medicinal and Aromatic Plant Science and Biotechnology ©2007 Global Science
Books
50. Achari B, Giri C, Saha CR, Dutta PK, Pakrashi SC (1992) A neo-clerodane
diterpene from Clerodendron inerme. Phytochemistry 31, 338-340.
Page 72
BIBLIOGRAPHY
51. Achari B, Giri C, Saha CR, Dutta PK, Pakrashi SC (1992) A neo-clerodane
diterpene from Clerodendron inerme. Phytochemistry 31, 338-340.
52. Joshi KC, Singh P, Mehra A (1979) Chemical investigation of the roots of
different Clerodendronspecies. Planta Medica 37, 64-66.
53.  OECD;  guidelines 425. Acute oral toxicity. Enviromental health and safety
monograph series on testing and assessment.2000.p. 24.
54. Banerjee  S.K.,  Chakravarti  R.N.,  et  al.  Constituents  of  Root Bark of
Clerodendrum serratum. J Phytochemistry. 1969; 8: 515.
55. Evaluation of antiallergic and anti-anaphylactic activity of ethanolic extract
of Sanseveiria trifasciataleaves (EEST) in rodentsRohan N. Andharea, Mayuresh
K. Rautb, Suresh R. Naikb,na Journal of Ethnopharmacology 142 (2012) 627–6.
56. Aliero, A.A., Jimoh, F.O., Afolayan, A.J., 2008. Antioxidant and antibacterial
properties  of  Sansevieria  hyacinthoides.  International  Journal  of  Plasma
Applied.Science 2, 103–110.
57. Benacerraf, B., 1978. A hypothesis to relate the specificity of T lymphocytes
and  the  activity  of  I  region  specific  Ir  genes  in  macrophages  and  B
lymphocytes.Journal of Ethnopharmacology 18, 133–141.
58.  Mast  cell  stabilizing  and  antiallergic  activity  of  Abrus  precatoriusin  the
management  of  asthma  DJ  Taur,  RY Patil  Asian  Pacific  Journal  of  Tropical
Medicine (2011)46-49
59.  Cavalher-Machado,  S.C.,  Rosas,  E.C.,  Brito,  F.,  de,  A.,  Heringe,  A.P.,
Oliveira, R.R., de,Kaplan, M.A.C., 2008. The anti-allergic activity of the acetate
fraction ofSchinus terebinthifoliusleaves in ice induced mice paws edema and
pleurisy. International Immunopharmacology 8, 1552–1560.
60.  Kumar  DA,  Ramu  P.  Effect  of  methanolic  extract  of  Benincasa  hispida
against histamine and acetylcholine induced  bronchospasm  in  guinea  pigs.  Ind
J Pharmacol. 2002; 34: 365–366.
Page 73
BIBLIOGRAPHY
61. Molet S, Hamid Q, Davoine F, Nutku E, Taha R,  Pagé  N.  2001.  IL-17  is
increased  in asthmatic  airways  and  induces  human bronchial fibroblasts to
produce cytokines. J Allergy Clin Immunol. 108: 430-438.
62.  Mitra  SK,  Gopumadhavan  S,  Venketaranganna  MV,  Antulikar  SD.
Antiasthmatic  and  antianaphylactic  effect  of  E-721  B,  a  herbal formulation.
Indian Journal Pharmacology 1999; 31: 133-137
63.  Dixon,  C.M.  and  Barnes,  P.J.  Bradykinin  induced  bronchoconstriction:
inhibition  by  nedocromil  sodium  and  sodium  cromoglycate.Br.  J.  Clin.
Pharmacol. 270: 831-836, 1989.
64.  Dixon,  M.,  Jackson,  D.M.  and  Richards,  I.M.  The  action  of  sodium
cromoglycate on C-fiber ending in dog lung. Br. J. Pharmacol.70: 11-13, 1980.
65. Englert   CE,  Wirth  K,  Gehring  D,  Fürst   U, Albus  U,  Scholz  W,
osenkranz  B, Schölkens  BA.  Airway  pharmacology  of the  potassium  channel
opener,   HOE   234,  in  guinea  pigs:   in  vitro   and  in  vivo  studies.  Eur  J
Pharmacol, 1992; 210: 69–75.
66. Murphy DJ,  Joran  ME,  Renninger  JE. Effects of adenosine agonists and
antagonists  on  pulmonary  ventilation  in conscious rats. Gen Pharmacol, 1993;
24: 943–954. International Journal of Herbal Drug Research, Vol I, Issue 1, 19-
27, 2011. Journal of Ethnopharmacology 76 (2001) 197– 200.
67. Baruah, M.C.C., Gupta, P.P., Amar, N., Patnaik, G.K., Dhawan, B.N., 1998.
Antiallergic  and  anti-anaphylactic  activity  of  Picroliv–a  standardised  iridoid
glycoside fraction ofPicrorhiza kurroa. Pharmacology Research 38, 487–492.
COMMENTS
               
Page 74
BIBLIOGRAPHY
S.N
O
PAGE
NO.
COMMEN
T
SIGNATURE DATE
Page 75
